IDSA rapid guideline strongly recommends timely age-appropriate COVID-19, RSV and influenza vaccines for immunocompromised adults and children (moderate certainty evidence), timed around immunosuppressive therapy and transplantation; coadministration is appropriate.
Guideline
Nellore et al. IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients